nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—KIT—myenteric nerve plexus—rectum cancer	0.0497	0.0754	CbGeAlD
Imatinib—PDGFRA—penis—rectum cancer	0.0352	0.0535	CbGeAlD
Imatinib—ABCA3—seminal vesicle—rectum cancer	0.0171	0.0259	CbGeAlD
Imatinib—DDR1—seminal vesicle—rectum cancer	0.0157	0.0239	CbGeAlD
Imatinib—ABCA3—urethra—rectum cancer	0.0135	0.0205	CbGeAlD
Imatinib—DDR1—smooth muscle tissue—rectum cancer	0.0132	0.02	CbGeAlD
Imatinib—ABCA3—mammalian vulva—rectum cancer	0.0129	0.0195	CbGeAlD
Imatinib—DDR1—urethra—rectum cancer	0.0125	0.0189	CbGeAlD
Imatinib—DDR1—mammalian vulva—rectum cancer	0.0119	0.018	CbGeAlD
Imatinib—HIPK4—female reproductive system—rectum cancer	0.0111	0.0169	CbGeAlD
Imatinib—ABCA3—vagina—rectum cancer	0.00996	0.0151	CbGeAlD
Imatinib—PIP4K2C—seminal vesicle—rectum cancer	0.00972	0.0147	CbGeAlD
Imatinib—DDR1—vagina—rectum cancer	0.00919	0.0139	CbGeAlD
Imatinib—CA14—seminal vesicle—rectum cancer	0.00843	0.0128	CbGeAlD
Imatinib—CA7—renal system—rectum cancer	0.00815	0.0124	CbGeAlD
Imatinib—PIP4K2C—urethra—rectum cancer	0.00769	0.0117	CbGeAlD
Imatinib—PIP4K2C—mammalian vulva—rectum cancer	0.00732	0.0111	CbGeAlD
Imatinib—NQO2—seminal vesicle—rectum cancer	0.00714	0.0108	CbGeAlD
Imatinib—LCK—urethra—rectum cancer	0.00683	0.0104	CbGeAlD
Imatinib—LCK—mammalian vulva—rectum cancer	0.0065	0.00986	CbGeAlD
Imatinib—ABCA3—lymph node—rectum cancer	0.00644	0.00977	CbGeAlD
Imatinib—PIP4K2C—female reproductive system—rectum cancer	0.00627	0.00952	CbGeAlD
Imatinib—CSF1R—seminal vesicle—rectum cancer	0.00627	0.00951	CbGeAlD
Imatinib—ABL2—vagina—rectum cancer	0.00599	0.0091	CbGeAlD
Imatinib—PDGFRA—smooth muscle tissue—rectum cancer	0.00596	0.00904	CbGeAlD
Imatinib—DDR1—lymph node—rectum cancer	0.00594	0.00902	CbGeAlD
Imatinib—NQO2—renal system—rectum cancer	0.00575	0.00873	CbGeAlD
Imatinib—PDGFRA—renal system—rectum cancer	0.00574	0.0087	CbGeAlD
Imatinib—CA9—female reproductive system—rectum cancer	0.00573	0.0087	CbGeAlD
Imatinib—SLC47A1—seminal vesicle—rectum cancer	0.00572	0.00868	CbGeAlD
Imatinib—KIT—seminal vesicle—rectum cancer	0.00569	0.00863	CbGeAlD
Imatinib—PIP4K2C—vagina—rectum cancer	0.00567	0.00861	CbGeAlD
Imatinib—NQO2—urethra—rectum cancer	0.00565	0.00857	CbGeAlD
Imatinib—PDGFRB—seminal vesicle—rectum cancer	0.00556	0.00843	CbGeAlD
Imatinib—SLC22A2—renal system—rectum cancer	0.00545	0.00827	CbGeAlD
Imatinib—CA3—vagina—rectum cancer	0.00542	0.00822	CbGeAlD
Imatinib—NQO2—mammalian vulva—rectum cancer	0.00538	0.00816	CbGeAlD
Imatinib—CA12—renal system—rectum cancer	0.00529	0.00803	CbGeAlD
Imatinib—CSF1R—smooth muscle tissue—rectum cancer	0.00525	0.00796	CbGeAlD
Imatinib—LCK—vagina—rectum cancer	0.00503	0.00764	CbGeAlD
Imatinib—CSF1R—urethra—rectum cancer	0.00496	0.00753	CbGeAlD
Imatinib—ABL1—seminal vesicle—rectum cancer	0.00495	0.00752	CbGeAlD
Imatinib—KIT—epithelium—rectum cancer	0.00494	0.0075	CbGeAlD
Imatinib—PDGFRB—epithelium—rectum cancer	0.00483	0.00733	CbGeAlD
Imatinib—KIT—smooth muscle tissue—rectum cancer	0.00476	0.00723	CbGeAlD
Imatinib—CSF1R—mammalian vulva—rectum cancer	0.00472	0.00717	CbGeAlD
Imatinib—PDGFRB—smooth muscle tissue—rectum cancer	0.00465	0.00706	CbGeAlD
Imatinib—SLC47A1—renal system—rectum cancer	0.00461	0.007	CbGeAlD
Imatinib—NQO2—female reproductive system—rectum cancer	0.00461	0.00699	CbGeAlD
Imatinib—PDGFRA—female reproductive system—rectum cancer	0.00459	0.00697	CbGeAlD
Imatinib—KIT—renal system—rectum cancer	0.00459	0.00696	CbGeAlD
Imatinib—SLC47A1—urethra—rectum cancer	0.00453	0.00687	CbGeAlD
Imatinib—KIT—urethra—rectum cancer	0.0045	0.00684	CbGeAlD
Imatinib—PDGFRB—renal system—rectum cancer	0.00448	0.0068	CbGeAlD
Imatinib—PDGFRB—urethra—rectum cancer	0.0044	0.00668	CbGeAlD
Imatinib—SLC47A1—mammalian vulva—rectum cancer	0.00431	0.00654	CbGeAlD
Imatinib—KIT—mammalian vulva—rectum cancer	0.00429	0.00651	CbGeAlD
Imatinib—CA12—female reproductive system—rectum cancer	0.00424	0.00643	CbGeAlD
Imatinib—CA1—renal system—rectum cancer	0.00419	0.00636	CbGeAlD
Imatinib—PDGFRB—mammalian vulva—rectum cancer	0.00419	0.00636	CbGeAlD
Imatinib—NQO2—vagina—rectum cancer	0.00417	0.00632	CbGeAlD
Imatinib—PDGFRA—vagina—rectum cancer	0.00416	0.0063	CbGeAlD
Imatinib—ABL1—smooth muscle tissue—rectum cancer	0.00415	0.00629	CbGeAlD
Imatinib—CSF1R—female reproductive system—rectum cancer	0.00404	0.00614	CbGeAlD
Imatinib—ABL1—renal system—rectum cancer	0.00399	0.00606	CbGeAlD
Imatinib—ABL1—urethra—rectum cancer	0.00392	0.00595	CbGeAlD
Imatinib—ABL2—lymph node—rectum cancer	0.00388	0.00588	CbGeAlD
Imatinib—SLC22A1—renal system—rectum cancer	0.00385	0.00584	CbGeAlD
Imatinib—ABL1—mammalian vulva—rectum cancer	0.00373	0.00566	CbGeAlD
Imatinib—SLC47A1—female reproductive system—rectum cancer	0.00369	0.0056	CbGeAlD
Imatinib—KIT—female reproductive system—rectum cancer	0.00367	0.00557	CbGeAlD
Imatinib—PIP4K2C—lymph node—rectum cancer	0.00367	0.00557	CbGeAlD
Imatinib—CSF1R—vagina—rectum cancer	0.00366	0.00555	CbGeAlD
Imatinib—PDGFRB—female reproductive system—rectum cancer	0.00359	0.00544	CbGeAlD
Imatinib—CA3—lymph node—rectum cancer	0.0035	0.00531	CbGeAlD
Imatinib—CA2—seminal vesicle—rectum cancer	0.00337	0.00512	CbGeAlD
Imatinib—ORM1—female reproductive system—rectum cancer	0.00336	0.00511	CbGeAlD
Imatinib—CA1—female reproductive system—rectum cancer	0.00336	0.0051	CbGeAlD
Imatinib—SLC47A1—vagina—rectum cancer	0.00334	0.00507	CbGeAlD
Imatinib—KIT—vagina—rectum cancer	0.00332	0.00504	CbGeAlD
Imatinib—LCK—lymph node—rectum cancer	0.00326	0.00494	CbGeAlD
Imatinib—PDGFRB—vagina—rectum cancer	0.00324	0.00492	CbGeAlD
Imatinib—ABL1—female reproductive system—rectum cancer	0.0032	0.00485	CbGeAlD
Imatinib—ABCG2—seminal vesicle—rectum cancer	0.00312	0.00474	CbGeAlD
Imatinib—CA2—epithelium—rectum cancer	0.00293	0.00445	CbGeAlD
Imatinib—ABL1—vagina—rectum cancer	0.00289	0.00439	CbGeAlD
Imatinib—CA2—smooth muscle tissue—rectum cancer	0.00282	0.00428	CbGeAlD
Imatinib—SLC22A1—vagina—rectum cancer	0.00279	0.00423	CbGeAlD
Imatinib—CA2—renal system—rectum cancer	0.00272	0.00412	CbGeAlD
Imatinib—NQO2—lymph node—rectum cancer	0.00269	0.00409	CbGeAlD
Imatinib—PDGFRA—lymph node—rectum cancer	0.00269	0.00408	CbGeAlD
Imatinib—PTGS1—seminal vesicle—rectum cancer	0.00261	0.00395	CbGeAlD
Imatinib—CA2—mammalian vulva—rectum cancer	0.00254	0.00386	CbGeAlD
Imatinib—ABCG2—urethra—rectum cancer	0.00247	0.00375	CbGeAlD
Imatinib—CYP1A2—renal system—rectum cancer	0.00242	0.00368	CbGeAlD
Imatinib—CSF1R—lymph node—rectum cancer	0.00237	0.00359	CbGeAlD
Imatinib—ABCG2—mammalian vulva—rectum cancer	0.00235	0.00357	CbGeAlD
Imatinib—CYP3A5—renal system—rectum cancer	0.00234	0.00355	CbGeAlD
Imatinib—PTGS1—epithelium—rectum cancer	0.00226	0.00343	CbGeAlD
Imatinib—PTGS1—smooth muscle tissue—rectum cancer	0.00218	0.00331	CbGeAlD
Imatinib—CA2—female reproductive system—rectum cancer	0.00218	0.0033	CbGeAlD
Imatinib—SLC47A1—lymph node—rectum cancer	0.00216	0.00328	CbGeAlD
Imatinib—CYP2C19—vagina—rectum cancer	0.00215	0.00326	CbGeAlD
Imatinib—KIT—lymph node—rectum cancer	0.00215	0.00326	CbGeAlD
Imatinib—PTGS1—renal system—rectum cancer	0.0021	0.00319	CbGeAlD
Imatinib—PDGFRB—lymph node—rectum cancer	0.0021	0.00318	CbGeAlD
Imatinib—CA2—vagina—rectum cancer	0.00197	0.00299	CbGeAlD
Imatinib—ORM1—lymph node—rectum cancer	0.00197	0.00299	CbGeAlD
Imatinib—CA1—lymph node—rectum cancer	0.00197	0.00298	CbGeAlD
Imatinib—PTGS1—mammalian vulva—rectum cancer	0.00196	0.00298	CbGeAlD
Imatinib—ABL1—lymph node—rectum cancer	0.00187	0.00284	CbGeAlD
Imatinib—CYP2C9—female reproductive system—rectum cancer	0.00184	0.00279	CbGeAlD
Imatinib—ABCG2—vagina—rectum cancer	0.00182	0.00277	CbGeAlD
Imatinib—CYP3A4—renal system—rectum cancer	0.00175	0.00266	CbGeAlD
Imatinib—ALB—lymph node—rectum cancer	0.00173	0.00262	CbGeAlD
Imatinib—CYP2D6—renal system—rectum cancer	0.00173	0.00262	CbGeAlD
Imatinib—CYP3A5—vagina—rectum cancer	0.00169	0.00257	CbGeAlD
Imatinib—PTGS1—female reproductive system—rectum cancer	0.00168	0.00255	CbGeAlD
Imatinib—ABCB1—seminal vesicle—rectum cancer	0.00154	0.00234	CbGeAlD
Imatinib—PTGS1—vagina—rectum cancer	0.00152	0.00231	CbGeAlD
Imatinib—CYP3A4—female reproductive system—rectum cancer	0.0014	0.00213	CbGeAlD
Imatinib—CYP2D6—female reproductive system—rectum cancer	0.00138	0.0021	CbGeAlD
Imatinib—ABCB1—epithelium—rectum cancer	0.00134	0.00203	CbGeAlD
Imatinib—CA2—lymph node—rectum cancer	0.00127	0.00193	CbGeAlD
Imatinib—ABCB1—renal system—rectum cancer	0.00124	0.00188	CbGeAlD
Imatinib—ABCB1—urethra—rectum cancer	0.00122	0.00185	CbGeAlD
Imatinib—ABCG2—lymph node—rectum cancer	0.00118	0.00179	CbGeAlD
Imatinib—ABCB1—mammalian vulva—rectum cancer	0.00116	0.00176	CbGeAlD
Imatinib—ABCB1—female reproductive system—rectum cancer	0.000994	0.00151	CbGeAlD
Imatinib—PTGS1—lymph node—rectum cancer	0.000984	0.00149	CbGeAlD
Imatinib—ABCB1—vagina—rectum cancer	0.000899	0.00136	CbGeAlD
Imatinib—ABCB1—lymph node—rectum cancer	0.000582	0.000882	CbGeAlD
Imatinib—PDGFRB—DAP12 signaling—KRAS—rectum cancer	0.000343	0.00101	CbGpPWpGaD
Imatinib—LCK—PDGFR-beta signaling pathway—KRAS—rectum cancer	0.000342	0.001	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.000342	0.001	CbGpPWpGaD
Imatinib—KIT—DAP12 signaling—HRAS—rectum cancer	0.000342	0.001	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—NRAS—rectum cancer	0.00034	0.000996	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	0.000338	0.000991	CbGpPWpGaD
Imatinib—ABL1—EGF/EGFR Signaling Pathway—KRAS—rectum cancer	0.000337	0.000989	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000337	0.000988	CbGpPWpGaD
Imatinib—KIT—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.000337	0.000988	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—KRAS—rectum cancer	0.000336	0.000986	CbGpPWpGaD
Imatinib—KIT—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000335	0.000982	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—HRAS—rectum cancer	0.000333	0.000976	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.000332	0.000973	CbGpPWpGaD
Imatinib—PDGFRA—B Cell Activation—KRAS—rectum cancer	0.000331	0.000972	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by SCF-KIT—HRAS—rectum cancer	0.000329	0.000964	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signal transduction—HRAS—rectum cancer	0.000328	0.000963	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by FGFR—HRAS—rectum cancer	0.000327	0.000958	CbGpPWpGaD
Imatinib—LCK—Signaling by Interleukins—HRAS—rectum cancer	0.000327	0.000958	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by ERBB2—HRAS—rectum cancer	0.000325	0.000953	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—NRAS—rectum cancer	0.000324	0.000951	CbGpPWpGaD
Imatinib—PDGFRA—DAP12 signaling—HRAS—rectum cancer	0.000323	0.000949	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—NRAS—rectum cancer	0.000323	0.000947	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.000322	0.000946	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR in disease—KRAS—rectum cancer	0.000322	0.000946	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 interactions—KRAS—rectum cancer	0.000322	0.000946	CbGpPWpGaD
Imatinib—KIT—Signaling by FGFR in disease—HRAS—rectum cancer	0.000321	0.000943	CbGpPWpGaD
Imatinib—KIT—DAP12 interactions—HRAS—rectum cancer	0.000321	0.000943	CbGpPWpGaD
Imatinib—KIT—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000321	0.000943	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—NRAS—rectum cancer	0.000321	0.000942	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—TP53—rectum cancer	0.00032	0.000939	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—NRAS—rectum cancer	0.00032	0.000937	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR—KRAS—rectum cancer	0.00032	0.000937	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.000319	0.000935	CbGpPWpGaD
Imatinib—KIT—Signaling by EGFR—HRAS—rectum cancer	0.000319	0.000934	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.000318	0.000933	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—TP53—rectum cancer	0.000317	0.00093	CbGpPWpGaD
Imatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000317	0.00093	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000317	0.000929	CbGpPWpGaD
Imatinib—KIT—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000316	0.000926	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by PDGF—KRAS—rectum cancer	0.000315	0.000925	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—NRAS—rectum cancer	0.000315	0.000924	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000315	0.000923	CbGpPWpGaD
Imatinib—KIT—Signaling by PDGF—HRAS—rectum cancer	0.000314	0.000922	CbGpPWpGaD
Imatinib—LCK—Signaling by SCF-KIT—KRAS—rectum cancer	0.00031	0.000911	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB4—HRAS—rectum cancer	0.00031	0.000908	CbGpPWpGaD
Imatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000304	0.000892	CbGpPWpGaD
Imatinib—PDGFRA—DAP12 interactions—HRAS—rectum cancer	0.000304	0.000892	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by FGFR in disease—HRAS—rectum cancer	0.000304	0.000892	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—TP53—rectum cancer	0.000303	0.000888	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR—HRAS—rectum cancer	0.000302	0.000884	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.000301	0.000882	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—NRAS—rectum cancer	0.000301	0.000882	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—NRAS—rectum cancer	0.000301	0.000882	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000299	0.000878	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—NRAS—rectum cancer	0.000299	0.000878	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000299	0.000877	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—TP53—rectum cancer	0.000299	0.000877	CbGpPWpGaD
Imatinib—NTRK1—Signaling by NGF—HRAS—rectum cancer	0.000299	0.000877	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—KRAS—rectum cancer	0.000298	0.000875	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—NRAS—rectum cancer	0.000298	0.000874	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by PDGF—HRAS—rectum cancer	0.000298	0.000873	CbGpPWpGaD
Imatinib—KIT—B Cell Activation—HRAS—rectum cancer	0.000297	0.000873	CbGpPWpGaD
Imatinib—LCK—Downstream signaling of activated FGFR—KRAS—rectum cancer	0.000297	0.000871	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000296	0.000867	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signal transduction—HRAS—rectum cancer	0.000296	0.000867	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—NRAS—rectum cancer	0.000295	0.000866	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR—HRAS—rectum cancer	0.000294	0.000863	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—NRAS—rectum cancer	0.000294	0.000863	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB2—HRAS—rectum cancer	0.000293	0.000859	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—KRAS—rectum cancer	0.000292	0.000857	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 signaling—HRAS—rectum cancer	0.000291	0.000855	CbGpPWpGaD
Imatinib—LCK—PDGFR-beta signaling pathway—HRAS—rectum cancer	0.000291	0.000852	CbGpPWpGaD
Imatinib—PDGFRA—Focal Adhesion—HRAS—rectum cancer	0.000288	0.000843	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.000287	0.000842	CbGpPWpGaD
Imatinib—ABL1—EGF/EGFR Signaling Pathway—HRAS—rectum cancer	0.000287	0.000841	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000286	0.000838	CbGpPWpGaD
Imatinib—KIT—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000285	0.000835	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—NRAS—rectum cancer	0.000283	0.000831	CbGpPWpGaD
Imatinib—PDGFRA—B Cell Activation—HRAS—rectum cancer	0.000282	0.000826	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—KRAS—rectum cancer	0.000279	0.000819	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—NRAS—rectum cancer	0.000278	0.000816	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—KRAS—rectum cancer	0.000278	0.000815	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—KRAS—rectum cancer	0.000276	0.000811	CbGpPWpGaD
Imatinib—ALB—Hemostasis—ITGA2—rectum cancer	0.000276	0.00081	CbGpPWpGaD
Imatinib—CA2—Metabolism—TYMS—rectum cancer	0.000276	0.000809	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—KRAS—rectum cancer	0.000275	0.000807	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000274	0.000804	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 interactions—HRAS—rectum cancer	0.000274	0.000804	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR in disease—HRAS—rectum cancer	0.000274	0.000804	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR—HRAS—rectum cancer	0.000272	0.000797	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	0.000271	0.000795	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.00027	0.000793	CbGpPWpGaD
Imatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000269	0.00079	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000269	0.00079	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by PDGF—HRAS—rectum cancer	0.000268	0.000786	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.000266	0.000781	CbGpPWpGaD
Imatinib—CA1—Metabolism—TYMS—rectum cancer	0.000265	0.000776	CbGpPWpGaD
Imatinib—LCK—Signaling by SCF-KIT—HRAS—rectum cancer	0.000264	0.000774	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000263	0.000771	CbGpPWpGaD
Imatinib—PDGFRB—Focal Adhesion—HRAS—rectum cancer	0.000259	0.00076	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.000259	0.000759	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—KRAS—rectum cancer	0.000259	0.000759	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—KRAS—rectum cancer	0.000259	0.000759	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—KRAS—rectum cancer	0.000258	0.000756	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—KRAS—rectum cancer	0.000256	0.000752	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—NRAS—rectum cancer	0.000255	0.000749	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000254	0.000746	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—HRAS—rectum cancer	0.000254	0.000744	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—KRAS—rectum cancer	0.000253	0.000742	CbGpPWpGaD
Imatinib—LCK—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000252	0.000741	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—HRAS—rectum cancer	0.000248	0.000729	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—KRAS—rectum cancer	0.000244	0.000715	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000243	0.000712	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—KRAS—rectum cancer	0.00024	0.000703	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—HRAS—rectum cancer	0.000237	0.000696	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—HRAS—rectum cancer	0.000236	0.000693	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—HRAS—rectum cancer	0.000235	0.000689	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—HRAS—rectum cancer	0.000234	0.000686	CbGpPWpGaD
Imatinib—CA9—Metabolism—TYMS—rectum cancer	0.000233	0.000682	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	0.00023	0.000676	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000229	0.000672	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—NRAS—rectum cancer	0.000225	0.00066	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—HRAS—rectum cancer	0.00022	0.000645	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.00022	0.000645	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—HRAS—rectum cancer	0.00022	0.000645	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—KRAS—rectum cancer	0.00022	0.000644	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—HRAS—rectum cancer	0.000219	0.000642	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—HRAS—rectum cancer	0.000218	0.000639	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000216	0.000634	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—HRAS—rectum cancer	0.000215	0.000631	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—NRAS—rectum cancer	0.000208	0.000611	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—HRAS—rectum cancer	0.000207	0.000608	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—NRAS—rectum cancer	0.000205	0.000601	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—HRAS—rectum cancer	0.000204	0.000597	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000195	0.000571	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—KRAS—rectum cancer	0.000194	0.000568	CbGpPWpGaD
Imatinib—SLC22A2—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000191	0.000561	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—HRAS—rectum cancer	0.000187	0.000548	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—KRAS—rectum cancer	0.000179	0.000526	CbGpPWpGaD
Imatinib—SLC22A1—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000178	0.000523	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—KRAS—rectum cancer	0.000176	0.000517	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—NRAS—rectum cancer	0.000171	0.000501	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—HRAS—rectum cancer	0.000165	0.000483	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—NRAS—rectum cancer	0.000164	0.000481	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—NRAS—rectum cancer	0.000162	0.000474	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—NRAS—rectum cancer	0.000161	0.000471	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—NRAS—rectum cancer	0.000158	0.000462	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—NRAS—rectum cancer	0.000155	0.000455	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—HRAS—rectum cancer	0.000152	0.000447	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—HRAS—rectum cancer	0.00015	0.00044	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—KRAS—rectum cancer	0.000147	0.000431	CbGpPWpGaD
Imatinib—SLC22A2—Neuronal System—HRAS—rectum cancer	0.000147	0.00043	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—NRAS—rectum cancer	0.000146	0.000427	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—NRAS—rectum cancer	0.000142	0.000416	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—KRAS—rectum cancer	0.000141	0.000414	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—NRAS—rectum cancer	0.00014	0.00041	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—KRAS—rectum cancer	0.000139	0.000408	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—KRAS—rectum cancer	0.000138	0.000406	CbGpPWpGaD
Imatinib—SLC22A1—Neuronal System—HRAS—rectum cancer	0.000137	0.000401	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—KRAS—rectum cancer	0.000136	0.000398	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—KRAS—rectum cancer	0.000134	0.000392	CbGpPWpGaD
Imatinib—LCK—Hemostasis—NRAS—rectum cancer	0.00013	0.000381	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000128	0.000374	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—KRAS—rectum cancer	0.000125	0.000368	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—HRAS—rectum cancer	0.000125	0.000366	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—KRAS—rectum cancer	0.000122	0.000358	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—rectum cancer	0.000121	0.000354	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—KRAS—rectum cancer	0.00012	0.000353	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—HRAS—rectum cancer	0.00012	0.000352	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—HRAS—rectum cancer	0.000118	0.000347	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—TYMS—rectum cancer	0.000118	0.000345	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—HRAS—rectum cancer	0.000118	0.000345	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—NRAS—rectum cancer	0.000117	0.000343	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—TYMS—rectum cancer	0.000117	0.000342	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—TYMS—rectum cancer	0.000116	0.000341	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—HRAS—rectum cancer	0.000115	0.000338	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—HRAS—rectum cancer	0.000114	0.000333	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000113	0.000332	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—TYMS—rectum cancer	0.000113	0.000331	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—NRAS—rectum cancer	0.000112	0.000329	CbGpPWpGaD
Imatinib—LCK—Hemostasis—KRAS—rectum cancer	0.000112	0.000328	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—TYMS—rectum cancer	0.000108	0.000318	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—HRAS—rectum cancer	0.000107	0.000312	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—HRAS—rectum cancer	0.000104	0.000304	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—HRAS—rectum cancer	0.000102	0.0003	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—KRAS—rectum cancer	0.000101	0.000295	CbGpPWpGaD
Imatinib—KIT—Immune System—NRAS—rectum cancer	9.94e-05	0.000292	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—rectum cancer	9.93e-05	0.000291	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—KRAS—rectum cancer	9.66e-05	0.000283	CbGpPWpGaD
Imatinib—LCK—Hemostasis—HRAS—rectum cancer	9.49e-05	0.000278	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NRAS—rectum cancer	9.41e-05	0.000276	CbGpPWpGaD
Imatinib—KIT—Disease—NRAS—rectum cancer	9.18e-05	0.000269	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NRAS—rectum cancer	8.77e-05	0.000257	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NRAS—rectum cancer	8.69e-05	0.000255	CbGpPWpGaD
Imatinib—KIT—Immune System—KRAS—rectum cancer	8.56e-05	0.000251	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—HRAS—rectum cancer	8.55e-05	0.000251	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NRAS—rectum cancer	8.48e-05	0.000249	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—TYMS—rectum cancer	8.42e-05	0.000247	CbGpPWpGaD
Imatinib—ABL1—Immune System—NRAS—rectum cancer	8.26e-05	0.000242	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—HRAS—rectum cancer	8.21e-05	0.000241	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—KRAS—rectum cancer	8.1e-05	0.000238	CbGpPWpGaD
Imatinib—KIT—Disease—KRAS—rectum cancer	7.9e-05	0.000232	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NRAS—rectum cancer	7.83e-05	0.00023	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NRAS—rectum cancer	7.76e-05	0.000228	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—KRAS—rectum cancer	7.55e-05	0.000221	CbGpPWpGaD
Imatinib—PDGFRA—Disease—KRAS—rectum cancer	7.48e-05	0.000219	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—KRAS—rectum cancer	7.3e-05	0.000214	CbGpPWpGaD
Imatinib—KIT—Immune System—HRAS—rectum cancer	7.27e-05	0.000213	CbGpPWpGaD
Imatinib—ALB—Metabolism—TYMS—rectum cancer	7.25e-05	0.000213	CbGpPWpGaD
Imatinib—ABL1—Immune System—KRAS—rectum cancer	7.11e-05	0.000209	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HRAS—rectum cancer	6.89e-05	0.000202	CbGpPWpGaD
Imatinib—LCK—Immune System—NRAS—rectum cancer	6.8e-05	0.0002	CbGpPWpGaD
Imatinib—PDGFRB—Disease—KRAS—rectum cancer	6.74e-05	0.000198	CbGpPWpGaD
Imatinib—KIT—Disease—HRAS—rectum cancer	6.72e-05	0.000197	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—rectum cancer	6.71e-05	0.000197	CbGpPWpGaD
Imatinib—ALB—Hemostasis—KRAS—rectum cancer	6.68e-05	0.000196	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TYMS—rectum cancer	6.51e-05	0.000191	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NRAS—rectum cancer	6.43e-05	0.000189	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HRAS—rectum cancer	6.42e-05	0.000188	CbGpPWpGaD
Imatinib—PDGFRA—Disease—HRAS—rectum cancer	6.36e-05	0.000186	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TYMS—rectum cancer	6.36e-05	0.000186	CbGpPWpGaD
Imatinib—LCK—Disease—NRAS—rectum cancer	6.28e-05	0.000184	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HRAS—rectum cancer	6.2e-05	0.000182	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NRAS—rectum cancer	6.09e-05	0.000178	CbGpPWpGaD
Imatinib—ABL1—Immune System—HRAS—rectum cancer	6.05e-05	0.000177	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TYMS—rectum cancer	5.99e-05	0.000176	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TYMS—rectum cancer	5.94e-05	0.000174	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—rectum cancer	5.93e-05	0.000174	CbGpPWpGaD
Imatinib—LCK—Immune System—KRAS—rectum cancer	5.86e-05	0.000172	CbGpPWpGaD
Imatinib—PDGFRB—Disease—HRAS—rectum cancer	5.73e-05	0.000168	CbGpPWpGaD
Imatinib—ALB—Hemostasis—HRAS—rectum cancer	5.68e-05	0.000166	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—KRAS—rectum cancer	5.53e-05	0.000162	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NRAS—rectum cancer	5.48e-05	0.000161	CbGpPWpGaD
Imatinib—LCK—Disease—KRAS—rectum cancer	5.41e-05	0.000159	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—KRAS—rectum cancer	5.24e-05	0.000154	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TYMS—rectum cancer	5.07e-05	0.000149	CbGpPWpGaD
Imatinib—LCK—Immune System—HRAS—rectum cancer	4.98e-05	0.000146	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—rectum cancer	4.92e-05	0.000144	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—KRAS—rectum cancer	4.72e-05	0.000138	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HRAS—rectum cancer	4.7e-05	0.000138	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—rectum cancer	4.66e-05	0.000137	CbGpPWpGaD
Imatinib—LCK—Disease—HRAS—rectum cancer	4.6e-05	0.000135	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HRAS—rectum cancer	4.45e-05	0.000131	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NRAS—rectum cancer	4.4e-05	0.000129	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—rectum cancer	4.19e-05	0.000123	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HRAS—rectum cancer	4.01e-05	0.000118	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TYMS—rectum cancer	3.92e-05	0.000115	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—KRAS—rectum cancer	3.79e-05	0.000111	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—rectum cancer	3.37e-05	9.87e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HRAS—rectum cancer	3.22e-05	9.44e-05	CbGpPWpGaD
